Start the conversation
"The [company] doth protest too much, methinks."
Our warning column on General Motors Co. (NYSE: GM) really seemed to resonate.
It generated a lot of emotion, eliciting some personal experiences from you folks and even a few suggestions that we recommend "shorting" the stock.
But it wasn't just our subscribers who responded to that analysis.
We also received a very strong response from GM itself.
We're on General Motors' (NYSE: GM) "Radar"
In my recent column,"Why GM's Recalls Are Worse Than You Think," I argued that I just don't buy in to Wall Street's talk of a turnaround at the once-great U.S. automaker.
I cautioned Strategic Tech Investor subscribers to not view GM's current recall problems as a "buying opportunity." In fact, I explained why it would be a bad decision to add the company's stock to your portfolio right now.
Indeed, I said you should just avoid GM stock altogether.
It hurt to write that. As a consumer, I've been a GM guy for as long as I can recall.
My family, too.
My concern, I said, was that GM still doesn't have all its problems under control.
As I told you:
New CEO Mary Barra, who took the job in January, recently fired 15 employees and disciplined five others involved in the faulty switches.
But GM as a whole seems to be in a state of denial about how extensive its problems really are – and I just don't think Barra has a firm grasp on quality control at her company yet.
She's talking tough and making quick moves, but Barra is facing, as she put it herself just last month, "a history of failures" for which "nobody took responsibility."
Some GM officials knew of these problems and covered them up for years.
Just one day after my column appeared, Tom Henderson, manager of global financial communications at GM, posted a lengthy response. The entire comment is shown below.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.